吉非替尼
医学
耐受性
内科学
肺癌
不利影响
胃肠病学
化疗
随机对照试验
癌症
表皮生长因子受体
作者
Masahiro Fukuoka,Seiji Yano,Giuseppe Giaccone,Tomohide Tamura,Kazuhiko Nakagawa,Jean‐Yves Douillard,Yutaka Nishiwaki,Johan Vansteenkiste,Shinzoh Kudoh,Danny Rischin,Richard Eek,Takeshi Horai,Kazumasa Noda,Ichiro Takata,Egbert F. Smit,Steven D. Averbuch,Angela Macleod,A. Feyereislova,Rui-Ping Dong,José Baselga
摘要
To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with pretreated advanced non-small-cell lung cancer (NSCLC).
科研通智能强力驱动
Strongly Powered by AbleSci AI
monere
劲秉
我是站长才怪
tuanheqi
爱静静
子车茗
寒食
HEIKU
双黄
buno
萧水白
三月聚粮
模糊中正
xjcy
Billy
李神奇
杳鸢
带头大哥
彭于彦祖
司南
皖公网安备34019202002308
